Professional Documents
Culture Documents
Conclusion
The diagnosis of perimenopause bleeding and prognostic
evaluation is based on the histopathological exam of the
endometrium after biopsy.
Special attention should be given to women who shows
endocrinometabolic risk profile for this type of cancer.
The study group,menstrual irregularity was evidenced mainly in
the age group 46-52 years(64,5%) and a large percentage of 35%
in multiparous.
The clinically dominant symptom was represented by
menometroragii 34% noting that in 62,1% of cases symptoms
consist in association of abnormal uterine bleedingclinical
events:menorrhagia-hypermenorea,menorrhagia-polimenoree
menorrhagia –intermenstrual bleeding.
In our study,leiomiofibroamele ,were the most common cause
of abnormal uterin bleeding(49,6%) in terms of histopathological.
The abnormal uterin bleeding are a result of conditions
hiperestrogenice where the endometrium is in proliferative
phase(in our study 3,12%)and untreated may develop endometrial
adenocarcinoma.
Progesterone hormone therapy was applied to 64% of patients.
Option to substitute progestin menopausal hormone therapy
remains an individual decision that requires careful consideration
of symptoms,risk factors,and the risk/ benefit ratio.